Cargando…

Dual oxidase 1: A predictive tool for the prognosis of hepatocellular carcinoma patients

Dual oxidase 1 (DUOX1), which is the main source of reactive oxygen species (ROS) production in the airway, can be silenced in human lung cancer and hepatocellular carcinomas. However, the prognostic value of DUOX1 expression in hepatocellular carcinoma patients is still unclear. We investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales:	CHEN, SHENGSEN, LING, QINGXIA, YU, KANGKANG, HUANG, CHONG, LI, NING, ZHENG, JIANMING, BAO, SUXIA, CHENG, QI, ZHU, MENGQI, CHEN, MINGQUAN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869938/ https://www.ncbi.nlm.nih.gov/pubmed/27108801 http://dx.doi.org/10.3892/or.2016.4745

Ejemplares similares

Comparison of hepatic and serum lipid signatures in hepatocellular carcinoma patients leads to the discovery of diagnostic and prognostic biomarkers
por: Lu, Yonghai, et al.
Publicado: (2017)

Serum MicroRNA Levels as a Noninvasive Diagnostic Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Liver Fibrosis
por: Bao, Suxia, et al.
Publicado: (2017)

A Critical Role of Peptidylprolyl Isomerase A Pseudogene 22/microRNA-197-3p/Peptidylprolyl Isomerase A Axis in Hepatocellular Carcinoma
por: Gu, Yuwei, et al.
Publicado: (2021)

The combination of three molecular markers can be a valuable predictive tool for the prognosis of hepatocellular carcinoma patients
por: Chen, Sheng-Sen, et al.
Publicado: (2016)

Promoter Hypermethylation Mediated Downregulation of FBP1 in Human Hepatocellular Carcinoma and Colon Cancer
por: Chen, Mingquan, et al.
Publicado: (2011)

STOML2 potentiates metastasis of hepatocellular carcinoma by promoting PINK1-mediated mitophagy and regulates sensitivity to lenvatinib
por: Zheng, Yahui, et al.
Publicado: (2021)

Overexpression of Epcam and CD133 Correlates with Poor Prognosis in Dual-phenotype Hepatocellular Carcinoma
por: Zhang, Jie, et al.
Publicado: (2020)

Prediction of Microvascular Invasion and Its M2 Classification in Hepatocellular Carcinoma Based on Nomogram Analyses
por: Chen, Shengsen, et al.
Publicado: (2022)

Corrigendum: Prediction of Microvascular Invasion and Its M2 Classification in Hepatocellular Carcinoma Based on Nomogram Analyses
por: Chen, Shengsen, et al.
Publicado: (2022)

Increased Expression of the Matrix-Modifying Enzyme Lysyl Oxidase-Like 2 in Aggressive Hepatocellular Carcinoma with Poor Prognosis
por: Choi, Jiwoon, et al.
Publicado: (2019)

Connection Between CDC20 Expression and Hepatocellular Carcinoma Prognosis
por: Zhang, Xianfeng, et al.
Publicado: (2021)

SESN2 correlates with advantageous prognosis in hepatocellular carcinoma
por: Chen, Shaosen, et al.
Publicado: (2017)

Integrated Genomic and Transcriptomic Analysis reveals key genes for predicting dual-phenotype Hepatocellular Carcinoma Prognosis
por: Wang, Yaobang, et al.
Publicado: (2021)

Comprehensive biological function analysis of lncRNAs in hepatocellular carcinoma
por: Wang, Dan, et al.
Publicado: (2020)

A novel immune-related genes prognosis biomarker for hepatocellular carcinoma
por: Wang, Kunpeng, et al.
Publicado: (2020)

Recent advances in optical aptasensors for biomarkers in early diagnosis and prognosis monitoring of hepatocellular carcinoma
por: Dong, Jia-Mei, et al.
Publicado: (2023)

Diagnosis, Therapy, and Prognosis for Hepatocellular Carcinoma
por: Ren, Zhigang, et al.
Publicado: (2020)

Increased expression of urotensin II is associated with poor prognosis in hepatocellular carcinoma
por: Liu, Dian-Gang, et al.
Publicado: (2016)

Numb Promotes Cell Proliferation and Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Wu, Jian, et al.
Publicado: (2014)

Caspase polymorphisms and prognosis of hepatocellular carcinoma
por: Zhang, Song, et al.
Publicado: (2017)

RNA binding protein-based risk score model for prognosis prediction of patients with hepatocellular carcinoma
por: Xu, Shengjun, et al.
Publicado: (2022)

Downregulation of amine oxidase copper containing 1 inhibits tumor progression by suppressing IL-6/JAK/STAT3 pathway activation in hepatocellular carcinoma
por: Ding, Qian, et al.
Publicado: (2021)

The role of dual oxidases in physiology and cancer
por: de Faria, Caroline Coelho, et al.
Publicado: (2020)

Circulating tumor cells and CXCR4 in the prognosis of hepatocellular carcinoma
por: Bai, Tao, et al.
Publicado: (2020)

NADPH Oxidase 1 and NADPH Oxidase 4 Have Opposite Prognostic Effects for Patients with Hepatocellular Carcinoma after Hepatectomy
por: Ha, Sang Yun, et al.
Publicado: (2016)

Correction: Numb Promotes Cell Proliferation and Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Wu, Jian, et al.
Publicado: (2022)

An Apoptotic Gene Signature for the Prognosis of Hepatocellular Carcinoma
por: Chen, Kunlun, et al.
Publicado: (2021)

Prognosis factors of predicting survival in spontaneously ruptured hepatocellular carcinoma
por: Wang, Peng, et al.
Publicado: (2022)

Implications of Stemness Features in 1059 Hepatocellular Carcinoma Patients from Five Cohorts: Prognosis, Treatment Response, and Identification of Potential Compounds
por: Mai, Haoming, et al.
Publicado: (2022)

Establishment and validation of a novel prognostic model for non-virus-related hepatocellular carcinoma
por: Jiang, Yu, et al.
Publicado: (2022)

FGFR4 and TGF-β1 Expression in Hepatocellular Carcinoma: Correlation with Clinicopathological Features and Prognosis
por: Chen, Zhixin, et al.
Publicado: (2013)

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

HVPG signature: A prognostic and predictive tool in hepatocellular carcinoma
por: Qi, Xiaolong, et al.
Publicado: (2016)

From imaging to clinical outcome: dual-region CT radiomics predicting FOXM1 expression and prognosis in hepatocellular carcinoma
por: Chen, Xianyu, et al.
Publicado: (2023)

A nomogram for predicting lymph node metastasis in early gastric signet ring cell carcinoma
por: You, Hongwei, et al.
Publicado: (2023)

Up-Regulation of hsa_circ_0000517 Predicts Adverse Prognosis of Hepatocellular Carcinoma
por: Wang, Xicheng, et al.
Publicado: (2019)

Integrated bioinformatics analysis revealed the regulation of angiogenesis by tumor cells in hepatocellular carcinoma
por: Huo, Meisi, et al.
Publicado: (2021)

Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma
por: Liu, Ting, et al.
Publicado: (2023)

Association of WWOX rs9926344 polymorphism with poor prognosis of hepatocellular carcinoma
por: Chen, Wanyong, et al.
Publicado: (2018)

The role of DEK protein in hepatocellular carcinoma for progression and prognosis
por: Lin, Li-juan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_05dh9vv9mep10ph8lrq91odokf